Anna Sureda Selected Research

Anna Sureda Research Topics

Disease

53	Lymphoma (Lymphomas) 01/2024 - 12/2003
43	Hodgkin Disease (Hodgkin's Disease) 12/2023 - 09/2002
36	Multiple Myeloma 02/2024 - 01/2002
32	Neoplasms (Cancer) 03/2024 - 12/2003
18	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 02/2006
17	COVID-19 01/2024 - 01/2020
15	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 08/2007
15	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2023 - 12/2008
14	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2024 - 04/2011
10	Infections 10/2023 - 07/2002
10	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2020 - 12/2009
9	Neutropenia 12/2020 - 01/2012
7	T-Cell Lymphoma (Lymphoma, T Cell) 01/2023 - 04/2007
6	Disease Progression 01/2024 - 11/2006
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2010 - 11/2003
5	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 03/2003
5	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2023 - 12/2003
4	Leukemia 01/2024 - 01/2006
4	Residual Neoplasm 02/2021 - 07/2002
4	Bronchiolitis Obliterans Syndrome 02/2019 - 04/2006
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 11/2008
3	Hematologic Diseases (Blood Diseases) 01/2023 - 10/2009
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2021 - 01/2019
2	Pathologic Complete Response 05/2024 - 07/2010
2	Cytokine Release Syndrome 01/2024 - 12/2022
2	Cytopenia 01/2023 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2006
2	Breakthrough Infections 01/2023 - 01/2022
2	Invasive Fungal Infections 07/2022 - 08/2016
2	Febrile Neutropenia 12/2020 - 06/2019
2	Sepsis (Septicemia) 01/2020 - 10/2013
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 08/2016
2	Enteropathy-Associated T-Cell Lymphoma 11/2017 - 03/2013
2	Mycosis Fungoides 10/2014 - 10/2010
2	Mucositis 01/2012 - 06/2007
2	Chromosome Aberrations (Chromosome Abnormalities) 10/2011 - 11/2003
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 11/2010 - 05/2010
2	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 06/2009 - 05/2009
2	Blast Crisis (Blast Phase) 04/2006 - 11/2003

Drug/Important Bio-Agent (IBA)

20	Chimeric Antigen ReceptorsIBA 05/2024 - 01/2020
12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 02/2016
10	Brentuximab VedotinIBA 12/2021 - 11/2012
9	Dexamethasone (Maxidex)FDA LinkGeneric 02/2024 - 10/2007
8	Bortezomib (Velcade)FDA Link 02/2024 - 10/2007
7	Melphalan (Alkeran)FDA LinkGeneric 08/2021 - 02/2006
7	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2020 - 06/2009
7	fludarabineIBA 10/2020 - 06/2005
6	axicabtagene ciloleucelIBA 01/2024 - 01/2022
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 01/2012
5	tisagenlecleucelIBA 01/2024 - 01/2021
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2006
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 02/2006
5	Rituximab (Mabthera)FDA Link 01/2020 - 05/2012
5	Imatinib Mesylate (Gleevec)FDA Link 06/2016 - 11/2003
4	COVID-19 VaccinesIBA 01/2024 - 01/2022
4	AntibodiesIBA 01/2023 - 01/2022
4	VaccinesIBA 01/2023 - 01/2022
4	Lenalidomide (CC 5013)FDA Link 01/2023 - 09/2012
4	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2022 - 09/2008
4	Vinblastine (Vinblastine Sulfate)FDA Link 04/2021 - 08/2013
4	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2021 - 08/2013
4	Dacarbazine (DIC)FDA LinkGeneric 04/2021 - 08/2013
4	PanobinostatIBA 01/2021 - 06/2012
4	Calcineurin InhibitorsIBA 10/2020 - 02/2016
4	Methotrexate (Mexate)FDA LinkGeneric 02/2019 - 02/2006
3	Oxygen (Dioxygen)IBA 01/2024 - 01/2022
3	Monoclonal AntibodiesIBA 09/2022 - 11/2006
3	plerixafor FDA Link 01/2020 - 09/2016
3	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2018 - 07/2004
3	Busulfan (Busulfex)FDA Link 01/2018 - 06/2005
3	SteroidsIBA 06/2016 - 11/2006
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2012 - 01/2009
2	daratumumabIBA 02/2024 - 01/2021
2	Immune Checkpoint InhibitorsIBA 11/2023 - 05/2020
2	carfilzomibIBA 10/2023 - 01/2021
2	Ferritins (Ferritin)IBA 05/2023 - 06/2007
2	glofitamabIBA 12/2022 - 01/2021
2	Prednisone (Sone)FDA LinkGeneric 08/2021 - 10/2016
2	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 12/2020 - 01/2020
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2020 - 05/2005
2	Etoposide (VP 16)FDA LinkGeneric 12/2018 - 10/2016
2	Bleomycin (Blenoxane)FDA LinkGeneric 10/2016 - 08/2013
2	DNA (Deoxyribonucleic Acid)IBA 10/2011 - 05/2005
2	Alemtuzumab (Campath)FDA Link 11/2008 - 10/2007

Therapy/Procedure

69	Stem Cell Transplantation 03/2024 - 01/2002
67	Therapeutics 05/2024 - 11/2003
52	Transplantation 01/2024 - 01/2002
27	Cell Transplantation 03/2024 - 11/2008
24	Drug Therapy (Chemotherapy) 01/2024 - 12/2003
19	Hematopoietic Stem Cell Transplantation 03/2024 - 09/2009
18	Homologous Transplantation 01/2022 - 02/2004
9	Autologous Transplantation 11/2020 - 11/2008
6	Immunotherapy 03/2024 - 05/2012
6	Salvage Therapy 12/2023 - 08/2007
6	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 01/2020
3	Combination Drug Therapy (Combination Chemotherapy) 12/2020 - 12/2003
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 06/2009 - 06/2002
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 10/2020
2	Drug Tapering 12/2020 - 11/2018
2	Highly Active Antiretroviral Therapy (HAART) 06/2009 - 09/2002